Редкие внекишечные проявления болезни Крона

1. Клинические рекомендации. Язвенный колит. Общероссийская общественная организация «Ассоциация колопроктологов России», Российская гастроэнтерологическая ассоциация. Рубрикатор клинических рекомендаций Минздрава России. 2024. ID: 193_2. Доступ: https://cr.minzdrav.gov.ru/preview-cr/193_2 (дата обращения – 16.06.2024). (Clinical guidelines. Ulcerative colitis. Association of Coloproctologists of Russia, Russian Gastroenterological Association. Rubricator of clinical guidelines of the Ministry of Healthcare of Russia. 2024. ID: 193_2. URL: https://cr.minzdrav.gov.ru/preview-cr/193_2 (date of access – 16.06.2024) (In Russ.)).

2. Клинические рекомендации. Болезнь Крона. Общероссийская общественная организация «Ассоциация колопроктологов России», Российская гастроэнтерологическая ассоциация. Рубрикатор клинических рекомендаций Минздрава России. 2024. ID: 176_2. Доступ: https://cr.minzdrav.gov.ru/preview-cr/176_2 (дата обращения – 16.06.2024). (Clinical guidelines. Crohn’s disease. Association of Coloproctologists of Russia, Russian Gastroenterological Association. Rubricator of clinical guidelines of the Ministry of Healthcare of Russia. 2024. ID: 176_2. URL: https://cr.minzdrav.gov.ru/preview-cr/176_2 (date of access – 16.06.2025) (In Russ.)).

3. Preotesoiu I, Alexandrescu L, Cimpineanu B, Tofolean IT, Stanciu IV, Herlo A et al. From gut to lungs: The hidden respiratory impacts of IBD: A systematic review of the literature. Int J Mol Sci. 2025 Sep 12;26(18):8912.

PMID: 41009481. PMCID: PMC12469750. https://doi.org/10.3390/ijms26188912.

4. Thao C, Lagstein A, Allen T, Dincer HE, Kim HJ. Crohn’s disease-associated interstitial lung disease mimicking sarcoidosis: A case report and review of the literature. Sarcoidosis Vasc Diffuse Lung Dis. 2016;33(3):288–91. PMID: 27758996.

5. Cebrian Garcia A, Ruiz-Clavijo D, Irisarri Garde R, Gonzalez de la Higuera Carnicer B, García de Galdiano Fernandez A, Fraile Gonzalez M. Bronchiolitis obliterans organizing pneumonia in Crohn’s disease. Gastroenterol Hepatol. 2019;42(8):496–97 (In English, Spanish).

PMID: 30578017. https://doi.org/10.1016/j.gastrohep.2018.11.004.

6. Hotermans G, Benard A, Guenanen H, Demarcq-Delerue G, Malart T, Wallaert B. Nongranulomatous interstitial lung disease in Crohn’s disease. Eur Respir J. 1996;9(2):380–82.

PMID: 8777981. https://doi.org/10.1183/09031936.96.09020380.

7. Freeman HJ, Davis JE, Prest ME, Lawson EJ. Granulomatous bronchiolitis with necrobiotic pulmonary nodules in Crohn’s disease. Can J Gastroenterol. 2004;18(11):687–90.

PMID: 15565210. https://doi.org/10.1155/2004/729689.

8. Inoue K, Kusunoki T, Fujii T. Organizing pneumonia as an extraintestinal manifestation of Crohn’s disease in a child. Pediatr Pulmonol. 2017;52(10):E64–E66.

PMID: 28493298. https://doi.org/10.1002/ppul.23717.

9. Zaman T, Watson J, Zaman M. Cryptogenic organizing pneumonia with lung nodules secondary to pulmonary manifestation of Crohn disease. Clin Med Insights Case Rep. 2017;10:1179547617710672.

PMID: 28579861. PMCID: PMC5439999. https://doi.org/10.1177/1179547617710672.

10. Mistry S, Kumarapeli AR, Mudrakola HV. A rare pulmonary manifestation of Crohn’s disease: Acute fibrinous and organizing pneumonia presenting as multifocal nodules. Respir Med Case Rep. 2024;48:101993.

PMID: 38357550. PMCID: PMC10865018. https://doi.org/10.1016/j.rmcr.2024.101993.

11. Prasoppokakorn T, Assanasen T, Chantranuwatana P, Suankratay C. EBV-associated lymphoid interstitial pneumonia in IBD patient: Case report and literature review. Respir Med Case Rep. 2020;30:101059.

PMID: 32373453. PMCID: PMC7193319. https://doi.org/10.1016/j.rmcr.2020.101059.

12. Li L, Liu P, Niu X, He C. Interstitial lung disease as an extraintestinal manifestation of Crohn’s disease in the time of COVID-19: A rare case report and review of the literature. J Inflamm Res. 2022;15:5733–37.

PMID: 36238767. PMCID: PMC9553307. https://doi.org/10.2147/JIR.S380879.

13. Basseri B, Enayati P, Marchevsky A, Papadakis KA. Pulmonary manifestations of inflammatory bowel disease: Case presentations and review. J Crohns Colitis. 2010;4(4):390–97.

PMID: 21122534. https://doi.org/10.1016/j.crohns.2010.03.008.

14. Bentur L, Lachter J, Koren I, Ben-Izhak O, Lavy A, Bentur Y, Rosenthal E. Severe pulmonary disease in association with Crohn’s disease in a 13-year-old girl. Pediatr Pulmonol. 2000;29(2):151–54.

PMID: 10639206. https://doi.org/10.1002/(sici)1099-0496(200002)29:2<151::aid-ppul10>3.0.co;2-w.

15. Suzuki A, Noro R, Omori J, Terasaki Y, Tanaka T, Fujita K et al. Pulmonary manifestation of inflammatory bowel disease: Two case reports. Respir Med Case Rep. 2023;45:101914.

PMID: 37719886. PMCID: PMC10500478. https://doi.org/10.1016/j.rmcr.2023.101914.

16. Garg C, Shrimanker I, Goel S, Mclaughlin J, Nookala V. Extraintestinal manifestations of crohn’s disease in the form of pulmonary nodules: A case report. Cureus. 2020;12(3):e7161.

PMID: 32257704. PMCID: PMC7112714. https://doi.org/10.7759/cureus.7161.

17. Arora H, Madani S, Debelenko LV, McGrath EJ, Mutyala R, Guglani L. Limited granulomatosis with polyangiitis in an adolescent with Crohn’s disease on infliximab therapy: Cause or coincidence? Clin Respir J. 2015;9(4):506–11.

PMID: 24865526. https://doi.org/10.1111/crj.12168

18. Kashima S, Moriichi K, Ando K, Ueno N, Tanabe H, Yuzawa S, Fujiya M. Development of pulmonary sarcoidosis in Crohn’s disease patient under infliximab biosimilar treatment after long-term original infliximab treatment: A case report and literature review. BMC Gastroenterol. 2021;21(1):373.

PMID: 34641810. PMCID: PMC8513323. https://doi.org/10.1186/s12876-021-01948-6.

19. Auffret M, Bene J, Lambert M, Gautier S. Pneumopathie interstitielle diffuse sous mésalazine: Un effet indésirable sous diagnostiqué? (Mesalazine-related interstitial lung disease: An under-diagnosed effect?). Therapie. 2014;69(6):531–32 (In French).

PMID: 25320942. https://doi.org/10.2515/therapie/2014205.

20. Makkawy EA, Alanazi MT, Yehia MF, Almazloum AM. Infliximab-induced interstitial pneumonitis: A case report. Cureus. 2023;15(6):e40812.

PMID: 37485130. PMCID: PMC10362944. https://doi.org/10.7759/cureus.40812.

21. Numakura T, Tamada T, Nara M, Muramatsu S, Murakami K, Kikuchi T et al. Simultaneous development of sarcoidosis and cutaneous vasculitis in a patient with refractory Crohn’s disease during infliximab therapy. BMC Pulm Med. 2016;16:30.

PMID: 26864464. PMCID: PMC4750217. https://doi.org/10.1186/s12890-016-0193-5.

22. Ruether DF, Menz A, Manthey CF. A disheveled man with inflammatory bowel disease and signs of infection. Gastroenterology. 2020;159(4):1247-1249.

PMID: 32511975. https://doi.org/10.1053/j.gastro.2020.05.075.

23. Caccaro R, Savarino E, D’Inca R, Sturniolo GC. Noninfectious interstitial lung disease during infliximab therapy: Case report and literature review. World J Gastroenterol. 2013;19(32):5377–80.

PMID: 23983443. PMCID: PMC3752574. https://doi.org/10.3748/wjg.v19.i32.5377.

24. Ananthakrishnan AN, Attila T, Otterson MF, Lipchik RJ, Massey BT, Komorowski RA, Binion DG. Severe pulmonary toxicity after azathioprine/6-mercaptopurine initiation for the treatment of inflammatory bowel disease. J Clin Gastroenterol. 2007;41(7):682–88.

PMID: 17667053. https://doi.org/10.1097/01.mcg.0000225577.81008.ee.

25. Rios Leon R, Jaureguizar Oriol A, Lopez-Sanroman A, Jimenez Castro D, Nieto Royo R, Albillos Martínez A. Acute severe pulmonary toxicity due to biosimilar infliximab in a Crohn’s disease patient. Gastroenterol Hepatol. 2019;42(2):104–5 (In English, Spanish).

PMID: 29519679. https://doi.org/10.1016/j.gastrohep.2018.01.013.

26. Despotes KA, Vigeland CL. Stelara struck: A case of noninfectious pneumonitis secondary to ustekinumab. BMC Pulm Med. 2022;22(1):280.

PMID: 35854305. PMCID: PMC9297594. https://doi.org/10.1186/s12890-022-02066-z.

27. Masuda T, Yoshida A, Ueno F, Hara S, Nabeta H, Umezawa S et al. A Patient with KL-6 elevation with anti-TNFα who could receive long-term use without interstitial pneumonia after class switch of anti-TNFα. Inflamm Intest Dis. 2019;4(1):35–40.

PMID: 31172011. PMCID: PMC6537466. https://doi.org/10.1159/000497778.

28. Azathioprine/infliximab/prednisolone. Reactions Weekly. 2022;1905;103.

https://doi.org/10.1007/s40278-022-14493-x.

29. Athayde RAB, Costa FMD, Nascimento ECTD, Sales RKB, Costa AN. Pulmonary involvement in Crohn’s disease. J Bras Pneumol. 2018;44(6):519–21.

PMID: 30726329. PMCID: PMC6459741. https://doi.org/10.1590/S1806-37562018000000055.

30. Барышева О.Ю., Атаманова А.С., Самусенко А.А., Стратегопуло В.А., Лютая Е.А., Везикова Н.Н., Егорова К.Е. Гломерулонефрит как вариант внекишечного проявления язвенного колита. Альманах клинической медицины. 2018;46(5):536–541. (Barysheva OYu, Atamanova AS, Samusenko AA, Strategopulo VA, Lyutaya EA, Vezikova NN, Egorova KE. Glomerulonephritis as a variant of extra-intestinal manifestation of ulcerative colitis. Almanakh klinicheskoy meditsiny = Almanac of Clinical Medicine. 2018;46(5):536–541 (In Russ.)).

EDN: SKCIPB. https://doi.org/10.18786/2072-0505-2018-46-5-536-541.

31. Joher N, Gosset C, Guerrot D, Pillebout E, Hummel A, Boffa JJ et al. Immunoglobulin A nephropathy in association with inflammatory bowel diseases: Results from a national study and systematic literature review. Nephrol Dial Transplant. 2022;37(3):531–39.

PMID: 33416845. https://doi.org/10.1093/ndt/gfaa378.

32. Treffel M, Champigneulle J, Meibody F, Laurain E, Frimat L, Busby-Venner H. Néphrite tubulo-interstitielle et maladie de Crohn, néphrotoxicité ou atteinte extradigestive de la maladie de Crohn ? À propos d’un cas (Tubulointerstitiel nephritis and Crohn’s disease, nephrotoxicity or extraintestinal manifestation of Crohn’s disease? About a case). Nephrol Ther. 2019;15(1):59–62 (In French).

PMID: 30503098. https://doi.org/10.1016/j.nephro.2018.07.406.

33. Choi H, Yim H, Park I. Concurrent Fabry disease and IgA nephropathy in a patient with Crohn’s disease: A case report. Nephrology (Carlton). 2025;30(1):e14419.

PMID: 39667372. https://doi.org/10.1111/nep.14419.

34. Terasaka T, Uchida HA, Umebayashi R, Tsukamoto K, Tanaka K, Kitagawa M et al. The possible involvement of intestine-derived IgA1: A case of IgA nephropathy associated with Crohn’s disease. BMC Nephrol. 2016;17(1):122.

PMID: 27596164. PMCID: PMC5011876. https://doi.org/10.1186/s12882-016-0344-1.

35. Choi JY, Yu CH, Jung HY, Jung MK, Kim YJ, Cho JH et al. A case of rapidly progressive IgA nephropathy in a patient with exacerbation of Crohn’s disease. BMC Nephrol. 2012;13:84.

PMID: 22866754. PMCID: PMC3724487. https://doi.org/10.1186/1471-2369-13-84.

36. Montero SS, Guix EM, Ausín MS, Garcia FI, Gomez BL, Martinez-Rosero CV et al. IgA nephropathy after long-term treatment with infliximab for Crohn’s disease Crohn’s disease, a review of two cases. Nefrologia (Engl Ed). 2024;44(4):599–601.

PMID: 39168811. https://doi.org/10.1016/j.nefroe.2023.02.010.

37. Lee M, Suzuki H, Kato R, Fukao Y, Nakayama M, Kano T et al. Renal pathological analysis using galactose-deficient IgA1-specific monoclonal antibody is a strong tool for differentiation of primary IgA nephropathy from secondary IgA nephropathy. CEN Case Rep. 2021;10(1):17–22. PMID: 32676896. PMCID: PMC7829275. https://doi.org/10.1007/s13730-020-00508-3

38. Forshaw MJ, Guirguis O, Hennigan TW. IgA nephropathy in association with Crohn’s disease. Int J Colorectal Dis. 2005;20(5):463–65.

PMID: 15668785. https://doi.org/10.1007/s00384-004-0696-z.

39. Arai O, Shibata N, Kuboki M, Ikeda H, Omoto K. (A case of Crohn’s disease concomitant with IgA nephropathy). Nihon Shokakibyo Gakkai Zasshi. 2013;110(7):1265–71 (In Japanese). PMID: 23831657.

40. Bhagat Singh AK, Jeyaruban AS, Wilson GJ, Ranganathan D. Adalimumab-induced IgA nephropathy. BMJ Case Rep. 2019;12(3):e226442.

PMID: 30936328. PMCID: PMC6453410. https://doi.org/10.1136/bcr-2018-226442.

41. Graziano F, Buse M, Cassata N, Lentini VL, Citrano M. IgA nephropathy in a child: Crohn’s disease-associated or adalimumab induced? Curr Med Res Opin. 2022;38(1):139–43.

PMID: 34866503. https://doi.org/10.1080/03007995.2021.2015155.

42. Boiten HJ, Honkoop P, Smak Gregoor PJ. Nefrotisch syndroom bij de ziekte van Crohn (Nephrotic syndrome in Crohn’s disease). Ned Tijdschr Geneeskd. 2015;159:A9264 (In Dutch). PMID: 26306485.

43. Gupta A, Pendyala P, Arora P, Sitrin MD. Development of the nephrotic syndrome during treatment of Crohn’s disease with adalimumab. J Clin Gastroenterol. 2011;45(3):e30–33.

PMID: 20975576. https://doi.org/10.1097/MCG.0b013e3181fae913

44. Dogahe D, Taghavi M, Cubilier E, Sanoussi S, Duttman R, Nortier J, do Carmo Filomena Mesquita M. Multiple complications of Crohn’s disease and the need for early and continuous multidisciplinary undertaking. J Med Cases. 2023;14(11):356–61.

PMID: 38029055. PMCID: PMC10681768. https://doi.org/10.14740/jmc4154.